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ABSTRACT
Knowledge about the molecular structure of protein kinase A (PKA)
isoforms is substantial. In contrast, the dynamics of PKA isoform
activity in living primary cells has not been investigated in detail.
Using a high content screening microscopy approach, we identified
the RIIb subunit of PKA-II to be predominantly expressed in a
subgroup of sensory neurons. The RIIb-positive subgroup included
most neurons expressing nociceptive markers (TRPV1, NaV1.8,
CGRP, IB4) and responded to pain-eliciting capsaicin with calcium
influx. Isoform-specific PKA reporters showed in sensory-neuron-
derived F11 cells that the inflammatory mediator PGE2 specifically
activated PKA-II but not PKA-I. Accordingly, pain-sensitizing
inflammatory mediators and activators of PKA increased the
phosphorylation of RII subunits (pRII) in subgroups of primary
sensory neurons. Detailed analyses revealed basal pRII to be
regulated by the phosphatase PP2A. Increase of pRII was followed
by phosphorylation of CREB in a PKA-dependent manner. Thus, we
propose RII phosphorylation to represent an isoform-specific
readout for endogenous PKA-II activity in vivo, suggest RIIb as a
novel nociceptive subgroup marker, and extend the current model of
PKA-II activation by introducing a PP2A-dependent basal state.
KEY WORDS: Protein kinase A, RII phosphorylation, cAMP
response element-binding protein, Nociception, Sensitization
INTRODUCTION
Protein kinase A (PKA) represents a family of tetrameric kinases
composed of regulatory (R) and catalytic (C) subunits. At low
cAMP concentrations, PKA is maintained as an inactive R2C2
holoenzyme. Binding of cAMP to R-subunits induces the
dissociation of the holoenzyme complex and release of C-
subunits facilitating substrate phosphorylation (Taylor et al.,
1990). Four regulatory (RIa, RIb, RIIa, RIIb) and four catalytic
subunits (Ca, Cb, Cc, PrKX) give rise to multiple isoenzymes,
categorized by their R-subunit class into PKA-I and PKA-II,
respectively. These isoenzymes differ in their biochemical
properties, expression pattern, interacting proteins, as well as
their subcellular localization (Pidoux and Taske´n, 2010). Also,
large variations in the quaternary structure of PKA-holoenzyme
complexes have been described (Boettcher et al., 2011; Kim et
al., 2007; Vigil et al., 2006; Wu et al., 2007; Zhang et al., 2012).
One difference between PKA-I and PKA-II is in their inhibitory
domain, which blocks the catalytic subunit. Whereas RI subunits
block the C-subunits by a non-phosphorylatable pseudosubstrate,
RII subunits carry a serine within that inhibitory domain
rendering them substrates of C-subunits. Recently, the analysis
of cell homogenates and protein crystals suggested that RII
subunits are fully phosphorylated already in the inactive PKA-II
complex (Manni et al., 2008; Zhang et al., 2012). However,
whether this also applies to PKA-II in intact cells in vivo has not
been conclusively investigated so far.
Knockout studies show that R-subunit isoforms are not
functionally redundant (Amieux et al., 2002; Brandon et al.,
1998; Cummings et al., 1996; Fischer et al., 2004; Huang et al.,
1995; Rao et al., 2004; Thiele et al., 2000). However, knockouts
of R-subunits have limitations in revealing specific functions of
PKA isoforms. Loss of one of the R-subunit isoforms might
induce compensatory upregulation of other regulatory isoforms or
result in increased free catalytic subunits, leading to uncontrolled
excessive PKA activity (Amieux et al., 1997; Amieux et al.,
2002). Therefore, isoform-specific reporter constructs have been
designed to analyze the differential involvement of PKA isoforms
in cellular functions (Prinz et al., 2006a). These approaches,
however, require transfection of cells and therefore cannot be
applied to many heterogeneous primary cell models. Thus, novel
approaches are required to be able to evaluate the regulation and
activity of endogenous PKA isoforms in wild-type cells.
Endogenous isoform-specific reporters of PKA activity are of
crucial importance for the analysis of adult nociceptive neurons,
which are highly heterogeneous and difficult to transfect.
Nociceptive neurons react to intense thermal, mechanical or
chemical stimuli and thereby initiate the feeling of pain (Basbaum
et al., 2009). They can be sensitized by various inflammatory
mediators including agonists of Gas-coupled GPCRs activating
the PKA pathway (Hucho and Levine, 2007). Indeed, PKA
represents an indirect target of common pain medications such as
opioids and non-steroidal anti-inflammatory drugs (NSAIDs)
(Pierre et al., 2009). PKA phosphorylates and sensitizes ion
channels such as the voltage-gated sodium channel NaV1.8 and
the transient receptor potential channel TRPV1, which are crucial
for the functionality of nociceptive neurons (Bhave et al., 2002;
England et al., 1996; Fitzgerald et al., 1999; Jeske et al., 2008;
Rathee et al., 2002; Wang et al., 2007; Zhang et al., 2008).
Moreover, activation of the cAMP response-element-binding
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protein (CREB) may occur downstream of PKA to induce gene
expression required for long-term sensitization (Ji et al., 2003).
Although most PKA studies in the context of pain have not taken
into account the different isoforms, knockout of the RIb subunit
indicated a small but significant involvement of PKA-I
(Malmberg et al., 1997). Whether PKA-II also is activated in
nociceptive neurons in response to inflammatory mediators is
unknown.
We set out to identify subgroup-specific expression of PKA
regulatory subunits in nociceptive neurons. We then tested
whether phosphorylation of RII subunits constitutes an
endogenous read out for changes in PKA-II activity in vivo. By
stimulating the neurons with various sensitizing inflammatory
mediators we aimed to characterize neuronal subgroups
responding to pain-sensitizing stimuli by the expression of
nociceptive markers. Our data from fully quantitative and
automated high content screening (HCS) microscopy suggest
RIIb can be used as a marker for nociceptive neurons. Moreover,
we propose a new dynamic model of baseline RII
phosphorylation and its relation to the activity of PKA catalytic
subunits.
RESULTS
All PKA regulatory subunits are expressed in DRG neurons
We analyzed the expression of the regulatory (RIa, RIb, RIIa,
RIIb) and the catalytic (Ca and Cb) subunits of PKA by real-time
PCR. Transcripts of all subunits were detected in mRNA samples
of lumbar rat dorsal root ganglions (DRGs; Fig. 1A).
To analyze the expression of the respective PKA subunit
proteins, we tested antibodies for their specificity in HeLa cells
transiently overexpressing GFP-tagged PKA subunits. All
antibodies recognized their respective targets in immunoblots
(Fig. 1B). We observed slight cross reactivity of the RIb antibody
to denatured RIa–GFP. Antibodies against the RII subunits,
however, proved to be highly specific. In immunostainings of
native GFP-tagged PKA regulatory subunits in intact HeLa cells,
they showed no sign of cross-reactivity (Fig. 1C) corroborating
tests of the RIIb antibody on tissues of Pkar2b knockout mice
(Inan et al., 2006). Using these evaluated antibodies, we detected
all PKA regulatory subunits in lysates of rat DRGs by
immunoblotting (Fig. 1D).
To evaluate the expression of endogenous PKA subunits in
DRG neurons at the single cell level, we established a
quantitative HCS microscopy approach suitable for the analysis
of large numbers of neurons. In brief, the microscope
automatically acquires images of immunostained cultures in
multi-well plates in up to four fluorescence channels. Neurons are
identified by automated image analysis according to their
expression of ubiquitin carboxyl-terminal hydrolase L1
(UCHL1, also known as PGP9.5) in combination with object
selection parameters optimized for the sphere-like geometry of
neurons after short-term culture (Fig. 1E; see Materials and
Methods section). Lumbar DRGs (L1–L6) yielded 31,28863231
analyzable neurons per rat with a unimodal UCHL1 and cell size
distribution (Fig. 1F,G).
Using this HCS approach and the evaluated antibodies, we
quantified the expression levels of PKA subunits in neurons and
non-neuronal cells. In line with findings indicating that the
expression pattern of b-isoforms is more restricted (Cadd and
McKnight, 1989), we detected b-isoforms only in neurons,
whereas a-subunits were expressed also in non-neuronal cells.
Ca/b, RIa, RIb and RIIa were found in all sensory neurons
(Fig. 1H). In contrast, RIIb was restricted to a subpopulation of
neurons. Similar staining patterns were present in frozen DRG
sections (Fig. 1I).
RIIb is predominantly expressed in nociceptive neurons
RIIb was expressed in 6860.6% (n54, mean 6 s.e.m., total of
44110 neurons) of all cultured DRG neurons and 5860.9% of all
neurons in sections (n54, mean 6 s.e.m., 12,706 neurons;
Fig. 2A). Nociceptive C- and Ad-neurons constitute about 60–
70% of DRG neurons and are smaller than other DRG neurons.
Indeed, the RIIb-positive [RIIb(+)] subpopulation was
significantly smaller than the overall neuronal population in
cultures (82766 mm2 versus 88767 mm2, P50.0005; n54, mean
6 s.e.m., 44,110 neurons) and sections (40163 mm2 versus
45567 mm2, P50.006; n54, mean 6 s.e.m., 12706 neurons;
Fig. 2B).
Sensory neurons are commonly grouped according the
expression of nociceptive subgroup markers such as TRPV1,
NaV1.8, calcitonin gene-related peptide (CGRP) and isolectin B4
(IB4), as well as of non-nociceptive markers such as
neurofilament 200 (NF200) (Belmonte and Viana, 2008). Using
threshold-based quantification, we found 35% of neurons were
TRPV1(+), 45% NaV1.8(+), 30% CGRP(+), 51% IB4(+) and
20% NF200(+) in overnight cultures (8000–10,000 neurons;
Fig. 2D) and 38% were TRPV1(+), 37% NaV1.8(+), 26%
CGRP(+), 40% IB4(+) and 37% NF200(+) in sections (1365–
4417 neurons, Fig. 2C,E). In line with previous reports NF200
was mainly detected in large-diameter neurons whereas the
nociceptive markers were expressed in smaller neurons (Fig. 2B).
Testing for co-expression with RIIb, 94% of TRPV1(+), 95%
of NaV1.8(+), 90% of CGRP(+) and 80% of IB4(+) neurons also
expressed RIIb in cultured neurons (Fig. 2D). Similarly, in
sections 95% of TRPV1(+), 88% of NaV1.8(+), 92% of CGRP(+)
and 82% of IB4(+) neurons co-expressed RIIb (Fig. 2E). In
contrast, only 40% and 30% of NF200(+) neurons co-expressed
RIIb in cultures and sections, respectively. Large NF200(+)
neurons are known to be Ab-fibers involved in proprioception but
not in nociception. They did not express RIIb (Fig. 2D,E).
Smaller neurons co-expressing RIIb and NF200 (<10%) could be
moderately myelinated Ad-fibers involved in the fast detection of
first pain (Basbaum et al., 2009). Therefore, RIIb expression
predominates in smaller neurons, including most neurons defined
by classical nociceptive markers.
Capsaicin-induced calcium influx occurs predominantly in
RIIb(+) neurons
To corroborate that RIIb is enriched in nociceptors, we required
functional confirmation. We therefore combined Fura-2-based
calcium imaging and immunofluorescence analysis using our
HCS platform. We stimulated DRG neurons with the pain-
inducing TRPV1 ligand capsaicin (250 nM), monitored the
calcium influx, and subsequently stained the same fixed cells
for RIIb expression (Fig. 2F). Capsaicin induced calcium influx
in 3565% of all neurons (n53, total of 942 neurons). In line with
immunofluorescence data, 9060.3% of the capsaicin-responsive
neurons were RIIb(+). Moreover, the mean response amplitude
was strongly increased in RIIb(+) neurons (Fig. 2G).
Raising cAMP levels increases phosphorylation of RII in
sensory neurons
Recent data (Manni et al., 2008; Martin et al., 2007; Zhang et al.,
2012) suggests that RII subunits should be fully phosphorylated
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ceFig. 1. All main PKA subunits are expressed in DRG neurons. (A) Real-time PCR analysis of the expression of PKA subunits in L1–L6 DRGs at the
transcript level. (B) Immunoblots showing GFP-tagged PKA subunits in lysates of transfected HeLa cells. All antibodies recognized their target proteins although
slight cross-reactivity of the RIb antibody with RIa–GFP was observed. (C) Confocal images of immunostained HeLa cells expressing GFP-tagged human PKA
subunits with no sign of cross-reactivity. Scale bar: 10 mm. (D) Immunoblots showing the expression of endogenous PKA subunits in whole DRG lysates. All
regulatory as well as the catalytic subunits were detected. (E) Representative fields of view showing the image analysis of stained DRG neurons. Green-
encircled neurons meet the specified object selection parameters, whereas red-encircled objects not. (F) Distribution of UCHL1 expression in DRG neurons
(n53, 9.66104 neurons). PDE, probability density estimation. (G) Cell size distribution of neurons analyzed in F. (H) Quantitative analysis of stained DRG
neurons after overnight culture. All DRG neurons expressed Ca/b, RIa, RIb and RIIa, whereas RIIb expression was restricted to a subpopulation (n51000
neurons per plot). The primary antibody was omitted in the controls. (I) Confocal images of immunostained frozen lumbar DRG sections (10 mm thick; scale bar:
50 mm) verifying the expression pattern in cultures.
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Fig. 2. See next page for legend.
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in the inactive PKA-II complex and dephosphorylated after
dissociation of the holoenzyme. To test this model in primary
sensory neurons, we first verified the specificity of monoclonal
antibodies generated against the phosphorylated epitopes of RIIa
(rabbit anti-pRII) or RIIb (mouse anti-pRII). Both antibodies
were specific for the phosphorylated epitopes of in vitro
phosphorylated recombinant RII subunits without discriminating
between RIIa and RIIb (Fig. 3A). Immunoblotting of DRG
lysates resulted in double bands of the expected molecular masses
(Fig. 3B). In frozen DRG sections, both pRII antibodies produced
highly similar staining patterns at the cellular level, although
there was nuclear immunoreactivity with the mouse anti-pRII,
which was not detected with the rabbit anti-pRII antibody
(Fig. 3C).
We then stimulated sensory neurons with the adenylyl cyclase
activator forskolin expecting a decrease in pRII signals. To our
surprise, forskolin did not decrease, but strongly increased, the
pRII signals (Fig. 3D). Signal intensities of both pRII antibodies
correlated significantly (Spearman’s r.0.9; Fig. 3E). Because
the dynamic range was higher for the rabbit pRII antibody, we
used this antibody for all following experiments.
We performed dose–response and kinetic experiments
pharmacologically raising the cellular cAMP concentration.
Stimulation with forskolin for 4 minutes increased pRII levels
2.3-fold with a half-maximal effective concentration (EC50) of
1.7 mM (Fig. 4A). Also the membrane-permeable and
phosphodiesterase-resistant cAMP analog Sp-8-Br-cAMPS-AM
dose-dependently induced RII phosphorylation (EC5051.3 mM).
Fig. 2. RIIb(+) neurons co-express nociceptive markers and respond to capsaicin. (A) Distribution of RIIb expression in cultured DRG neurons and frozen
DRG sections detected by immunostaining. RIIb expression was restricted to a subpopulation of neurons, 6860.5% in culture and 5860.5% in sections. Dashed
lines indicate gating thresholds set at local minima to discriminate between RIIb(2) and RIIb(+) neurons. PDE, probability density estimation. (B) Size distribution
of RIIb(+) DRG neurons compared with those expressing UCHL1, TRPV1, NaV1.8, CGRP, IB4 or NF200. (C) Confocal images of lumbar DRG sections triple-
stained for UCHL1, RIIb and additional markers (10 mm thick; scale bar: 50 mm). The RIIb(+) subpopulation included most TRPV1(+), NaV1.8(+), CGRP(+) and
IB(+) neurons, but lacked larger NF200(+) neurons. (D) Density plots showing single cell data of cultured DRG neurons labeled for RIIb and markers TRPV1,
NaV1.8, CGRP, IB4 and NF200 (.8000 neurons/plot). Black lines indicate gating thresholds to discriminate between subpopulations. (E) Density plots showing
single cell data of DRG neurons in sections labeled for RIIb and markers [see C, total of 1365 (TRPV1), 2738 (NaV1.8), 4417 (CGRP), 3075 (IB4), 3853 (NF200)
neurons]. (F) Mean calcium traces after stimulation with medium (Med), capsaicin (Cap, 250 nM), and potassium chloride (KCl, 30 mM). (G) Statistical analysis
of the traces shown in F at baseline, 10 seconds after medium, 10 and 30 seconds after capsaicin, and 10 seconds after KCl stimulation [n53, total of 647
RIIb(+) and 295 RIIb(2) neurons, two-way ANOVA with Bonferroni test]. Values are means 6 s.e.m. *P,0.05; **P,0.01; ****P,0.0001.
Fig. 3. PKA-mediated phosphorylation of RII subunits represents a measure of PKA-II activity. (A) Immunoblots of in vitro phosphorylated RII subunits
showing that mouse (mo) and rabbit (ra) pRII antibodies were specific for the phospho-epitopes without discriminating between RII isoforms. (B) Immunoblots of
rat DRG lysates probed with mouse or rabbit pRII antibodies. Both antibodies gave rise to double bands at 53 kDa indicating specificity for RII subunits.
(C) Confocal images of frozen DRG sections stained for UCHL1, RIIa/b and pRII. The staining pattern of both pRII antibodies was similar and resembled the
combined pattern of RIIa/b. (D) Stained DRG cultures after stimulation for 4 minutes with forskolin (10 mM) or solvent control (0.1% DMSO). Forskolin stimulation
increased pRII signal intensities. (E) Quantitative immunofluorescence analysis of forskolin (10 mM) and control (0.1% DMSO)-treated DRG neurons. Signal
intensities of both pRII antibodies correlated significantly (n.2000 neurons/condition, Spearman’s r.0.9).
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Blocking phosphodiesterases with 3-isobutyl-1-methylxanthine
(IBMX) to inhibit cAMP degradation also increased RII
phosphorylation (Fig. 4A). The kinetic response to these
compounds was long-lasting, reaching plateau values after
5 minutes (Fig. 4B).
The homeostatic level of phospho-RII depends on PP2A
The model of Zhang et al. suggests an immediate phosphorylation
of RII subunits even if PKA-II is in a holoenzyme complex
(Zhang et al., 2012). Our data, however, show that activation of
PKA-II results in a further increase of pRII levels. This suggests
that the baseline homeostatic level of phosphorylated RII subunits
is controlled by an interplay of catalytic subunits and
phosphatases such as calcineurin (PP2B) (Oliveria et al., 2007;
Rangel-Aldao and Rosen, 1976) or PP2A (Manni et al., 2008).
We tested whether inhibition of phosphatases PP1, PP2A or
calcineurin results in increased homeostatic baseline pRII levels.
Treatment with the PP1/PP2A inhibitor calyculin A for 4 minutes
resulted in a dose-dependent increase of pRII levels with an EC50
of 1.7 mM (Fig. 4C). Treatment with the PP1 inhibitor
tautomycetin or the calcineurin inhibitor cyclosporine A did not
result in accumulation of phosphorylated RII subunits (Fig. 4C).
The homeostatic level of phospho-RII is increased in RIIb(+) neurons
Next we compared the basal phosphorylation levels of RIIb-
negative [RIIb(2)] and RIIb(+) neurons at the single cell level.
RIIb(+) neurons showed higher pRII levels than RIIb(2) neurons
even in the unstimulated condition (2.560.1-fold; n53, 17,191
neurons; Fig. 4D). This difference was maintained after
stimulation with forskolin [2.160.1-fold in RIIb(2) versus
2.360.2-fold in RIIb(+); n53, 17,715 neurons] indicating that
homeostatic pRII levels are regulated in a subgroup-specific
manner.
Inflammatory mediators induce transient RII phosphorylation in
subpopulations of sensory neurons
We applied a customized mixture modeling approach for the
analysis of RIIb(2) and RIIb(+) neurons. The method provides
the population-based estimate of responding versus non-
responding neurons in a threshold-free manner even if
populations are largely overlapping (see the Materials and
Methods section for details). Forskolin induced RII
phosphorylation in 81.862.7% of RIIb(2) and 99.560.2% of
RIIb(+) neurons (n53, 17,715 neurons) indicating that most
neurons have the potential to react to increased levels of cAMP
(Fig. 4E).
Next we tested whether PKA-II is downstream of known
sensitizing inflammatory mediators activating Gas-coupled
GPCRs. Stimulation with prostaglandin E2 (PGE2) for
30 seconds resulted in a dose-dependent RII phosphorylation
with an EC50 of 46 nM (Fig. 5A). Prostacyclin (PGI2,
EC50574 nM) induced a twice as strong response as PGE2
(Fig. 5A). Testing of several monoamines including serotonin (5-
HT), histamine, dopamine, and the b-adrenergic agonist
isoproterenol (Iso) revealed that only 5-HT and Iso, but
not histamine and dopamine, significantly induced RII
Fig. 4. Pharmacological modulators of cAMP cause long-lasting RII phosphorylation opposed by PP2A-mediated dephosphorylation. (A) Dose–
response curves of forskolin (EC5051.7 mM), Sp-8-Br-cAMPS-AM (EC5051.3 mM) and IBMX after 4 minutes stimulation (n53, .2000 neurons/condition; one-
way ANOVA with Tukey’s test). (B) Time-course experiment indicating long-lasting RII phosphorylation by forskolin (10 mM), Sp-8-Br-cAMPS-AM (10 mM) and
IBMX (100 mM). (C) Dose-dependent induction of pRII by calyculin A (EC5051.7 mM), but not cyclosporine A or tautomycetin after stimulation for 4 minutes.
(D) Cell density plots showing pRII/RIIb-labeled DRG neurons stimulated with forskolin (10 mM), Sp-8-Br-cAMPS-AM (10 mM), or treated with 0.1% DMSO
(control; .4000 neurons/condition). Dashed lines indicate gating thresholds to discriminate between RIIb(2) and RIIb(+) neurons. (E) Distribution of pRII
intensities in RIIb(2) and RIIb(+) neurons treated with forskolin (10 mM, red line) compared with the solvent control (0.1% DMSO, gray filled area). Threshold-
free mixture modeling (see Materials and Methods section) was applied to estimate the number of non-responsive (dashed black line) and responsive cells
(dashed green line) from the modeled population (blue line). PDE, probability density estimation. Values are means 6 s.e.m. *P,0.05; **P,0.01; ***P,0.001.
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phosphorylation (Fig. 5B). The EC50 values were 14 nM for 5-HT
and 33 nM for Iso, respectively. In contrast to the effects of cAMP
analogs, PKA-II activation induced by inflammatory mediators
was transient. Maximal responses were reached within 1 minute,
returning to baseline within 5 to 60 minutes (Fig. 5C).
In order to analyze the response to each inflammatory mediator
at the single cell level, we stimulated DRG neurons for 1 and
4 minutes and immunostained for pRII and RIIb (Fig. 5D). PGE2
broadly activated RIIb(+) as well as RIIb(2) neurons, whereas
responses to PGI2, 5-HT, and Iso were restricted to
Fig. 5. Inflammatorymediators induce transient RII phosphorylation in different subpopulations of sensory neurons. (A) Dose-dependent induction of pRII
after stimulation for 30 seconds with PGE2 (EC50546 nM) and PGI2 (EC50574 nM) (n53, .2000 neurons/condition; one-way ANOVA with Tukey’s test).
(B) Dose–response curves of serotonin (5-HT, EC50514 nM) and isoproterenol (Iso, EC50533 nM) after 30 seconds stimulation. Related monoamines dopamine
(DA) and histamine (His) did not change pRII levels. (C) Time-course experiment showing transient RII phosphorylation by PGE2 (10 mM), PGI2 (10 mM), 5-HT
(1 mM) and Iso (1 mM). (D) Density plots showing pRII/RIIb-labeled DRG neurons stimulated for 1 minute with PGE2 (10 mM), PGI2 (10 mM), 5-HT (1 mM) or Iso
(1 mM) (.4000 neurons/condition). Dashed lines indicate gating thresholds to discriminate between RIIb(2) and RIIb(+) neurons. (E) Fold changes of pRII
intensities in RIIb(2) (white bars) and RIIb(+) (black bars) neurons after stimulation for 1 minute (n53,.2000 neurons/condition, two-way ANOVA with Bonferroni
test). (F) Distribution of pRII intensities from stimulated (red lines) and solvent control-treated (gray filled areas) RIIb(2) (upper panel) and RIIb(+) (lower panel) DRG
neurons shown in D. Mixture modeling (see Materials and Methods section) was applied to estimate the number of non-responsive (dashed black line) and
responsive cells (dashed green line) from the modeled population (blue line). Notably, RIIb(+) neurons selectively react to PGI2. (G) Average pRII levels in non-
neuronal cells after stimulation (n53,.2000 neurons/condition; one-way ANOVA with Tukey’s test). Values are means6 s.e.m. *P,0.05; **P,0.01; ***P,0.001.
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subpopulations. Notably, PGI2- and 5-HT-induced RII
phosphorylation was significantly higher in RIIb(+) neurons (Fig. 5E).
To show that raising cAMP levels also induces RII
phosphorylation in non-neuronal cells such as glia, we
quantified pRII levels in non-neuronal cells using a modified
cell identification algorithm, which selects smaller sized, bright
nuclei of cells lacking expression of UCHL1. We found that only
forskolin and Iso, but not PGI2 and 5-HT, significantly increased
pRII levels in non-neuronal cells (Fig. 5G).
We used our mixture modeling approach to quantify the
percentage of responsive neurons and found strong differences
between the inflammatory mediators with respect to the activated
subpopulations. PGE2 induced RII phosphorylation in 6965% of
RIIb(2) and 9265% of RIIb(+) neurons after 1 minute
stimulation (Fig. 5F, n53, 10,464 neurons). Similar results
were obtained after 4 minutes stimulation [6763% of RIIb(2)
and 82610% of RIIb(+) neurons, n53, 16,933 neurons]. Of note,
PGI2 was selectively acting on RIIb(+) neurons after 1 minute
(9960.4%, n53, 10,505 neurons) and 4 minutes stimulation
(9960.6%, n53, 10,555 neurons), but had no significant effect
on RIIb(2) neurons. 5-HT stimulation caused RII
phosphorylation in subpopulations of RIIb(2) and RIIb(+)
neurons after 1 minute [4965% of RIIb(2) and 6262% of
RIIb(+) neurons, n53, 9470 neurons] and 4 minutes [5861% of
RIIb(2) and 6361% of RIIb(+) neurons, n53, 16,352 neurons].
Iso induced RII phosphorylation in both neuron populations after
1 minute stimulation [4363% of RIIb(2) and 5663% of RIIb(+)
neurons, n53, 9808 neurons].
Thus, changes in pRII levels allow subgroup-specific analysis
identifying that some inflammatory mediators activate PKA-II in
most neurons (e.g. PGE2) and others specifically act on subgroups
(e.g. PGI2, 5-HT).
PGI2- and 5-HT-induced RII phosphorylation is followed by PKA-
dependent CREB phosphorylation
The expression of RIIb and the dynamic phosphorylation of RII
allowed us to analyze the kinetics of ligand-induced signaling in a
subgroup-specific manner. It remained unclear, however, if
phosphorylation of RII subunits indicates increased activity of
PKA-II catalytic subunits. We therefore tested whether the
increase of pRII is followed by increased phosphorylation of a
PKA downstream target such as the transcription factor CREB.
CREB is phosphorylated at Ser133 within its kinase-inducible
domain by several kinases including PKA and ERK1/2.
Stimulation with forskolin induced nuclear CREB
phosphorylation in DRG neurons detected with a phospho-
Ser133-specific antibody (Fig. 6A). Quantification of signal
intensities from time course experiments revealed a long-lasting
response upon forskolin stimulation (Fig. 6B). Inflammatory
mediators by contrast induced transient CREB phosphorylation,
peaking 5 minutes after stimulation (Fig. 6B). In agreement with
CREB being a downstream target of PKA, the response kinetics
were slightly slower than the pRII response (Fig. 5C).
For an estimate of the number of responding cells, we analyzed
pCREB/RIIb-labeled neurons stimulated for 4 minutes (Fig. 6C).
Basal pCREB levels were 1.360.01-fold higher in RIIb(+)
compared with RIIb(2) neurons (n53, 11,268 neurons), probably
reflecting the higher basal PKA-II activity in RIIb(+) neurons
shown above. In line with the pRII-based subgroup analysis, we
found that forskolin and PGE2 induced CREB phosphorylation in
both populations to a similar extent, whereas responses to PGI2
and 5-HT were significantly higher in RIIb(+) neurons (Fig. 6D).
Applying mixture modeling revealed that forskolin stimulation
induced CREB phosphorylation in most neurons [7061% of
RIIb(2) and 8862% of RIIb(+) neurons, n53, 10,407 neurons;
Fig. 6E]. PGE2 induced a broad and rather weak response in both
populations [5463% of RIIb(2) and 7467% of RIIb(+) neurons,
n53, 11,392 neurons]. PGI2-induced CREB phosphorylation was
restricted to RIIb(+) neurons (7963%, n53, 11,641 neurons). 5-
HT acted on both populations, but the response was enhanced in
RIIb(+) neurons [3866% of RIIb(2) and 6566% of RIIb(+)
neurons, n53, 10,797 neurons].
To analyze whether CREB phosphorylation was dependent on
PKA but not ERK1/2, we pretreated the neurons for 1 hour with
the PKA inhibitor H89 or with the MEK inhibitor PD98059.
CREB phosphorylation was blocked by the inhibitor of PKA but
not of MEK (Fig. 6F). To verify the effectiveness of PD98059,
ERK1/2 phosphorylation induced by the nerve growth factor
(1 nM, 30 minutes) was blocked by PD98059 (Fig. 7A).
Therefore, induction of RII phosphorylation indicates that there
is activation of PKA-II as confirmed by PKA-dependent
phosphorylation of its downstream target, CREB.
PGE2 selectively activates PKA-II in DRG-derived F11 cells
Our pRII assay specifically detects the activation of PKA-II but
not of PKA-I. In order to test all PKA isoforms for activation by
inflammatory mediators, we employed bioluminescence
resonance energy transfer (BRET) sensors. These are composed
of Renilla luciferase-conjugated R-subunits (hRIa-RLuc, hRIIa-
RLuc and hRIIb-RLuc) as bioluminescent donor proteins and
GFP-tagged catalytic subunits as acceptor proteins (Diskar et al.,
2007; Prinz et al., 2006a; Prinz et al., 2006b). In the inactive PKA
complex the close proximity of luciferase and GFP results in
energy transfer and a strong BRET signal. Activation of PKA by
cAMP results in dissociation of the subunits reducing BRET
signals.
Because BRET requires recombinant expression of fusion
proteins, we switched to DRG-derived F11 cells. Forskolin
strongly activated PKA-Ia, PKA-IIa and PKA-IIb sensors as
indicated by the drop of the BRET signal to 71610%, 3067%
and 2264%, respectively (Fig. 7B–D). The inflammatory
mediator PGE2 also activated PKA. In contrast to forskolin,
PGE2 selectively activated PKA-IIa (6566%) and PKA-IIb
sensors (7769%).
DISCUSSION
Dynamics of PKA-RII phosphorylation
Combinatorial assembly of catalytic and regulatory subunits
results in diverse isoforms of the PKA family. Their quaternary
structures differ substantially (Taylor et al., 2012). A detailed
analysis of isoform-specific cellular functions, however, remains
challenging. Approaches to directly detect the activation of
endogenous isoforms in primary cells models are largely missing.
It was unclear whether changes in RII phosphorylation reflect the
process of PKA-II activation. Early biochemical studies on PKA-
II purified from bovine cardiac muscle showed that a large
proportion of PKA-II is phosphorylated in vivo (Rangel-Aldao et
al., 1979). Another report suggests that RII subunits are fully
phosphorylated in non-stimulated cardiomyocytes (Manni et al.,
2008). Accordingly, these researchers found that activation of
PKA resulted in a phosphatase-dependent loss of basal RII
phosphorylation detected in cell lysates (Manni et al., 2008). The
assumption that RII subunits are fully phosphorylated in the
inactive holoenzyme complex was also suggested by the recently
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resolved crystal structure of the PKA-RIIb tetrameric
holoenzyme (RIIb2:C2) (Zhang et al., 2012). Only the reaction
products ADP and phosphorylated RIIb were detected after
diffusion of MgATP into the RIIb2:C2 crystals in the absence of
cAMP (Zhang et al., 2012). Based on these findings, Zhang et al.
proposed that the RIIb2:C2 holoenzymes are instantly
autophosphorylated in the inactive state. Based on this model,
cAMP-induced dissociation of the complex would result in
dephosphorylation of free pRII by nearby phosphatases (Manni et
al., 2008; Oliveria et al., 2007; Zhang et al., 2012).
Fig. 6. PGI2- and 5-HT-induced CREB phosphorylation depends on PKA and occurs predominantly in RIIb(+) neurons. (A) Immunostaining of phospho-
CREB (pCREB) in DRG neurons stimulated for 15 minutes with forskolin (10 mM) or treated with solvent (0.1% DMSO; control). Scale bar: 20 mm. (B) Time
course of pCREB by forskolin (10 mM), PGE2 (10 mM), PGI2 (10 mM) or 5-HT (1 mM) (n53, .2000 neurons/condition; one-way ANOVA with Tukey’s test).
(C) Cell density plots showing pCREB/RIIb-labeled DRG neurons stimulated for 4 minutes with forskolin (10 mM), PGE2 (10 mM), PGI2 (10 mM) or 5-HT (1 mM)
(n.4000 neurons per plot). Dashed lines indicate gating thresholds to discriminate between RIIb(2) and RIIb(+) neurons. (D) Fold changes of pCREB intensities
in RIIb(2) (white bars) and RIIb(+) (black bars) neurons after 4 minutes stimulation with forskolin or inflammatory mediators (n53, .2000 neurons/condition,
Two-way ANOVA with Bonferroni test). (E) Distribution of pCREB intensities from stimulated (red lines) and solvent-treated (gray filled areas) RIIb(2) (upper
panel) and RIIb(+) (lower panel) DRG neurons shown in C. Mixture modeling was applied to estimate the number of non-responsive (dashed black line) and
responsive cells (dashed green line) from the modeled population (blue line). (F) Fold changes of pCREB from DRG neurons pretreated for 1 hour with the PKA
inhibitor H89 (25 mM) or with the MEK inhibitor PD98059 (50 mM) and then stimulated with PGI2 (1 mM) or 5-HT (1 mM) for 4 minutes (n53, .2000 neurons/
condition, one-way ANOVA with Tukey’s test). CREB phosphorylation was blocked by the PKA, but not the MEK inhibitor. Values are means 6 s.e.m. *P,0.05;
**P,0.01; ***P,0.001.
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Using a novel HCS microscope approach for the analysis of
adult sensory neurons, we found high variability of basal pRII
levels. Especially high levels were detected in sensory neurons
with high expression levels of RIIb (Fig. 4D). Interestingly, these
neurons coexpress markers of nociceptive neurons, suggesting
that they are functionally distinct (Fig. 2C–E). In contrast to the
model of PKA-II activation depicted above, raising cAMP levels
resulted in increased phosphorylation of endogenous RII subunits
in our experiments. The induction of pRII was observed in
response to activators of adenylyl cyclases, cAMP analogs, block
of cAMP hydrolysis by phosphodiesterases, and ligand induced
activation of Gas-coupled GPCRs (Figs 4, 5).
We believe, however, that our data are not contradictory to the
recently published data. Rather, our findings extend the current
model by further information about the basal state. Instant
phosphorylation of RII, as suggested by Zhang et al. (Zhang et al.,
2012), could be counterbalanced in vivo by rapid
dephosphorylation even in the absence of cAMP (Fig. 7E).
Indeed, blocking the phosphatase PP2A in the absence of any
stimulatory signal resulted in increased basal pRII signals
(Fig. 4C). This model is supported by the observed decrease of
the Kd for the interaction of RII with C-subunits following RII
phosphorylation by factor of five (Rangel-Aldao and Rosen,
1976; Zimmermann et al., 1999). Also studies using BRET
sensors demonstrate that phosphorylation of RII subunits is
required for the full dissociation of PKA-II holoenzymes in cell
lines (Diskar et al., 2007). Thus, we propose to extend the current
model as follows: (I) RII subunits are instantly phosphorylated by
C-subunits within the tetrameric RII2C2 complex; (II) pRII has a
higher probability for brief dissociation of the tetrameric
complex; (III) free pRII subunits are rapidly dephosphorylated
by PP2A and/or calcineurin, which induces reassociation of the
complex followed by a new cycle of RII phosphorylation and
dephosphorylation (Fig. 7E).
The introduction of rapid turn-over at pRII in the basal
state has important implications. Our data indicate that
Fig. 7. (A) The MEK inhibitor PD98059 (50 mM) blocks nerve growth factor (NGF)-induced (1 nM, 30 minutes) ERK1/2 phosphorylation. (B–D) PGE2 selectively
activates PKA-II, but not PKA-I, in transiently transfected F11 cells. DRG-derived F11 cells were transfected with isoform-specific BRET sensors composed of
GFP-hCa and hRIa-RLuc (B), hRIIa-RLuc (C), or hRIIb-RLuc (D), 48 hours prior to stimulation with forskolin (10 mM) or PGE2 (10 mM). Control transfections with
fusion proteins only were performed to determine the background (n53; one-way ANOVA). Values are means 6 s.e.m. *P,0.05; **P,0.01; ***P,0.001.
(E) Proposed model of PKA-II activation. We extended the model as proposed by Zhang et al. (Zhang et al., 2012). RII subunits are phosphorylated by
C-subunits within the tetrameric RII2C2 complex resulting in dissociation of the complex. Rapid dephosphorylation by PP2A induces reassociation of the PKA-II
complex followed by a new cycle of RII phosphorylation/dephosphorylation. Activation of adenylyl cyclases (AC) results in local production of cAMP, which binds
to RII subunits. Binding of cAMP stabilizes RII phosphorylation and leads to the dissociation of the PKA-II complex resulting in release of active C-subunits
phosphorylating nearby substrates. Degradation of cAMP by phosphodiesterases (PDEs) is followed by dephosphorylation and reassociation with free
C-subunits.
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measuring endogenous pRII levels allows the isoform-specific
analysis of endogenous PKA-II activation even in hard to
transfect cells such as the adult nociceptive neurons. The
kinetics of RII phosphorylation measured here closely
resemble the kinetics observed using the FRET-based sensor
AKAR2 that monitors the activity of C-subunits (Zhang et al.,
2005). Furthermore, changes at the level of pRII resemble
substrate phosphorylation because the response strength,
kinetics and number of responding cells is similar for RII
and CREB phosphorylation (Figs 5, 6). Also the dissociation
constants from dose–response experiments are consistent with
previous reports derived from reporter-based methods (Prinz et
al., 2006a). In line with our findings, increased RII
phosphorylation was recently detected in spinal cord neurons
following intrathecal injection of NMDA (Kim et al., 2011).
As we found pRII responses in glia cells, this also applies to
non-neuronal cell types (Fig. 5G). We conclude that pRII
antibodies can be used to analyze the isoenzyme-specific
activation of endogenous PKA-II.
The investigation of the dynamics of RII phosphorylation
revealed surprising aspects. Phosphorylation sites of RII are
excellent substrates for the phosphatase calcineurin (PP2B),
which has also been reported to colocalize with RII at the C-
terminus of AKAP79/150 in neurons (Oliveria et al., 2007;
Rangel-Aldao and Rosen, 1976). We therefore assumed that
dephosphorylation of RII is mediated by calcineurin. However, in
nociceptive neurons it is not calcineurin but PP2A that seems to
be involved in the regulation of the basal state (Fig. 4C). This
observation is in line with findings in cell lysates of forskolin-
stimulated cardiac myocytes in which dephosphorylation of RII
subunits could also be inhibited by the PP2A inhibitor calyculin
A (Manni et al., 2008).
PKA-RIIb, a subgroup marker predominantly expressed in
nociceptive neurons
We set out to investigate subgroup specificity of PKA isoforms.
We found RIIb to be selectively expressed in a subgroup of
sensory neurons (<60%, Fig. 2A). Interestingly, the neurons in
this subgroup include most neurons labeled by classical
nociceptive markers and they are activated by the pain-eliciting
TRPV1 agonist capsaicin (Fig. 2C–G). Our findings therefore
reveal that not only specific ion channels, but also signaling
components modulating these channels, show subgroup-specific
expression patterns and are enriched in nociceptive neurons. This
suggests that also the intracellular signaling machinery defines
the function of nociceptive subgroups. Currently there is no
marker that exclusively identifies nociceptive neurons. As for the
classical markers, RIIb is expressed predominantly in nociceptive
neurons and thus may be used equally as a marker of nociceptive
neurons. Nevertheless, further studies are required to clarify
whether RIIb expression is restricted to nociceptive subgroups
only or to what extend RIIb expression occurs also in some non-
nociceptive subgroups (e.g. itch-specific neurons).
Inflammatory mediators modulate various ion channels
including TRPV1, NaV1.8 and P2X3 in nociceptive neurons in
a PKA-dependent manner (Bhave et al., 2002; England et al.,
1996; Fitzgerald et al., 1999; Moriyama et al., 2005; Rathee et al.,
2002; Wang et al., 2007). Sensitization of TRPV1 depends on its
association with AKAP79/150 to form a signaling complex that
includes PKA (Bhave et al., 2002; Jeske et al., 2008; Rathee et al.,
2002; Schnizler et al., 2008; Zhang et al., 2008). This implies that
PKA-II isoforms bound to AKAPs are more relevant for
sensitization of ion channels in nociceptive neurons. Supporting
this, our data demonstrate that the transcription factor CREB is
downstream of PKA-II-mediated sensitization signaling and is
predominantly activated in RIIb(+) neurons. This suggests a
PKA-II-dependent induction of transcriptional long-term changes
such as seen for example during chronification of pain.
We found that PGE2 selectively activates PKA-II, but not
PKA-I (Fig. 7B–D). Also, a study using BRET sensors in COS-7
cells showed that stimulation of b-adrenergic receptors with
isoproterenol selectively dissociated RIIa holoenzymes but not
RIa holoenzymes (Prinz et al., 2006a). In addition, we found
inflammatory mediators to activate PKA-II in RIIb(+) as well as
RIIb(2) neurons. This suggests that RIIa and RIIb are activated
downstream of Gas-coupled GPCRs in sensory neurons and are
functionally redundant. Isoform replacement could therefore
explain why knockout mice of individual RII isoforms present
rather mild phenotypes (Brandon et al., 1998; Cummings et al.,
1996; Rao et al., 2004).
Our pRII assay allowed us to investigate the dynamics of PKA-
II in subgroups of sensory neurons. To what extent inflammatory
mediators act on sensory neurons has not been analyzed in detail
so far. We found some inflammatory mediators to activate PKA-
II in nearly all DRG neurons (e.g. PGE2), whereas others acted on
subgroups of RIIb(2) and RIIb(+) neurons (e.g. 5-HT, Iso) or
even specifically activated RIIb(+) neurons only (e.g. PGI2;
Fig. 5F). The observation that PGI2 induces RII and CREB
phosphorylation selectively in RIIb(+) neurons underlines the
importance of RIIb as a possible marker predominantly expressed
in nociceptive subgroups. Peripheral sensitization by PGI2 acting
on IP1 receptors is well described (Pulichino et al., 2006). Mice
deficient for the PGI2 receptor showed reduced inflammation and
pain comparable with that of NSAID treatment in models of acute
and chronic inflammation (Murata et al., 1997; Pulichino et al.,
2006). In contrast to PGE2, PGI2-induced sensitization is
restricted to the peripheral sensory system and does not occur
within the spinal cord (Pulichino et al., 2006; Reinold et al.,
2005). This corroborates that RIIb(+) neurons are enriched for
nociceptive neurons and identifies PKA-RIIb downstream of IP1
receptors as a potential novel therapeutic target in the peripheral
nervous system.
The great challenge of signaling analysis is the identification of
isoform-specific actions in subgroups of primary cells. The novel
HCS microscopy approach presented here enables the
investigation of PKA-II dynamics in intact primary sensory
neurons. Analyzing more than 1 million neurons, this approach
elucidated the dynamic nature of the PKA-II basal state as well as
subgroup-specific actions of inflammatory mediators. Beyond the
suggestion of a new potential therapeutic target and the extension
of the current model of PKA-II activation, our work further
proposes a general assay for the analysis of endogenous PKA-II
activation in primary cells.
MATERIALS AND METHODS
Animals
Male Sprague Dawley rats (200–225 g, 8 weeks old) were obtained from
Harlan. All animal experiments were performed in accordance with the
German animal welfare law with permission of the District Government
of Berlin (LaGeSo, Berlin, license ZH120). For tissue collection, rats
were killed by CO2 inhalation.
Antibodies
The following antibodies were used: rabbit polyclonal anti-Ca (Santa
Cruz, no. sc-903; WB 1:5000, IC 1:500), rabbit monoclonal anti-RIa
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(Cell Signaling, no. 5675; WB 1:5000, IC 1:1000), rabbit polyclonal anti-
RIb (Abm, no. Y051648; WB 1:2500, IC 1:500), mouse monoclonal anti-
RIIa (BD Transduction Laboratories, no. 612242; WB 1:5000, IC 1:500),
mouse monoclonal anti-RIIb (BD, no. 610625; WB 1:5000, IC 1:2000),
mouse monoclonal anti-phospho-RIIb (S114) (BD, no. 612550; WB
1:2000, IC 1:1000), rabbit monoclonal anti-phospho-RIIa (S96) (Abcam,
no. ab32390; WB 1:2000, IC 1:1000), chicken polyclonal anti-UCHL1
(Novus, no. NB110-58872; IC 1:2000), rabbit polyclonal anti-TRPV1
(Alomone, no. ACC-030; IC 1:1000), mouse monoclonal anti-
neurofilament 200 labeled with Alexa Fluor 488 (Sigma-Aldrich, no.
N0142; IC 1:500), rabbit polyclonal anti-CGRP (Bachem, no. T-4032; IC
1:1000), rabbit polyclonal anti-NaV1.8 (Abcam, no. ab63331; IC 1:500),
FITC-conjugated isolectin B4 (Sigma, L2895; IC 1:2500), highly cross-
adsorbed Alexa-Fluor-647-, -594 and -488-conjugated secondary
antibodies (Invitrogen).
Reagents
Forskolin (no. F3917), 3-isobutyl-1-methylxanthine (IBMX, no. I7018),
GR113808 (#G5918), serotonin hydrochloride (5-HT, no. H9523), histamine
dihydrochloride (no. H7250), dopamine hydrochloride (no. H8502), (2)-
isoproterenol hydrochloride (no. I6504), cyclosporine A, and capsaicin were
from Sigma-Aldrich. Phosphate tris(acetoxymethyl)ester (PO4-AM3, no.
P030-003), 8-bromoadenosine 39,59-cyclic monophosphorothioate, Sp-
isomer and acetoxymethyl ester (Sp-8-Br-cAMPS-AM, no. B029) were
from Biolog LSI. PGE2 (no. 14010) and PGI2 (no. 18220) were from Cayman.
PD98059 was from Calbiochem. H89 dihydrochloride, calyculin A and
tautomycetin were from Tocris. All drugs were prepared as 10–100 mM
stocks in distilled water, PBS, DMSO or ethanol.
Real-time PCR
RNA was isolated using Trizol (Invitrogen). One mg total RNA was
reverse transcribed using the Multi-Scribe RT kit (Applied Biosystems).
Reactions were performed in triplicate using TaqMan probes. FAM-
coupled TaqMan probes (Rn00566036, Rn01756450, Rn00709403,
Rn01293014, Rn01432302, Rn01748544, Rn00667869) were from
Applied Biosystems.
Immunoblotting
L1–L6 DRGs were pulverized in liquid nitrogen and lysed in 1 ml lysis
buffer (15 mM Tris-HCl (pH 7.5), 8 M urea, 8.7% glycerol, 1% sodium
dodecyl sulfate, 143 mM b-mercaptoethanol). Lysates were
homogenized (QIAShredder, Qiagen), denatured for 5 minutes at 95 C˚,
loaded (10 mg), separated by SDS-PAGE, and transferred to PVDF
membranes (Millipore). After blocking in Tris-buffered saline (TBST)
with 2.5% milk powder at 4 C˚ overnight, membranes were incubated
with the primary antibody diluted in TBST for 3 hours at room
temperature (RT). After three washes with TBST (10 minutes, RT), a
chemiluminescence detection system was used (Thermo Fisher).
Expression of PKA regulatory subunits in HeLa cells
HeLa cells were seeded on 12 mm coverslips placed in 24-well plates at a
density of 2.56104 cells/well and transfected with Lipofectamine 2000
(Invitrogen) on the following day, according to the manufacturer’s
instructions. C-terminally GFP-tagged R-subunits are described
elsewhere (Prinz et al., 2006a). Cells were fixed with
paraformaldehyde (PFA, 4%, 10 minutes) after 36 hours and stained as
described below.
In vitro phosphorylation of PKA regulatory subunits
Recombinant human RIIa and RIIb (5 mg) were diluted in 50 ml 20 mM
MOPS (pH 7.0), 50 mM NaCl, 10 mM MgCl2 and 1 mM ATP. Samples
were mixed, split in half, spiked with either 100 nM PKA-Ca or buffer,
and incubated for 30 minutes at RT. Reactions were stopped by adding
56SDS sample buffer and heating to 95 C˚ for 10 minutes.
DRG neuron cultures
L1–L6 DRGs were removed, desheathed, pooled and incubated in
Neurobasal A medium supplemented with B27 (Invitrogen) and
collagenase P (Roche; 0.2 U/ml) for 1 hour at 37 C˚ in 5% CO2. The
neurons were dissociated by trituration with fire-polished Pasteur
pipettes. Axon stumps and disrupted cells were removed by BSA
gradient centrifugation (15% BSA, 120 g, 8 minutes). Cells were
resuspended in Neurobasal A supplemented with B27 medium, plated
on 96-well imaging plates (Greiner) or onto glass coverslips precoated
with poly-L-ornithin (0.1 mg/ml) and laminin (5 mg/ml), and
incubated overnight (37 C˚, 5% CO2). Neuron density was ,1500
neurons/cm2.
Frozen DRG sections
L1–L6 DRGs were fixed with 2% PFA for 4 hours on ice, rinsed three
times for 20 minutes with PBS at RT, submerged in 30% sucrose in PBS
at 4 C˚ overnight, embedded in Tissue Tek (EMS Science), and snap
frozen on dry ice. Frozen blocks were cut into 10 mm sections, mounted
on slides, dried for 30 minutes at RT, and stored at 280 C˚. Thawed
sections were fixed in 2% PFA for 10 minutes at 4 C˚, rinsed in PBS for
30 minutes, and stained as described below.
Stimulation of DRG neurons
DRG neurons were stimulated 24 hours after isolation. Half of the
volume (50 ml) was removed from the culture well, mixed with the
compound in 96-well V-bottom plates, and added back to the same well.
Controls were treated the same way but mixed with solvent only. The
cells were fixed by adding 100 ml 8% PFA [final concentration (f.c.) 4%]
for 10 minutes at RT. Stimulations were performed in a heated (37 C˚)
water bath or within the incubator. Neurons were stimulated with the
compounds and concentrations as indicated in the text and reagents
section.
Immunofluorescence staining
After blocking and permeabilization (2% goat serum, 1% BSA, 0.1%
Triton X-100, 0.05% Tween 20 for 1 hour, at RT), sections or cells were
incubated with primary antibodies in 1% BSA in PBS at 4 C˚ overnight.
After three washes with PBS (10 minutes, RT), cells were incubated with
secondary antibodies (1:1000, 1 hour, RT). After three final washes
(30 minutes, RT), the plates were stored at 4 C˚ until scanning. Sections
were mounted with Fluoromount-G (Southern Biotech). Refer to
antibodies section for dilutions.
Quantitative microscopy
Stained cultures in 96-well plates were scanned using a Cellomics
ArrayScan VTI. Images of 5126512 pixels were acquired with a 106
objective and analyzed using the Cellomics software package. Briefly,
images of UCHL1 stainings were background corrected (low pass
filtration), converted to binary image masks (fixed threshold), segmented
(geometric method), and neurons were identified by the object selection
parameters – size: 120–4000 mm2; circularity (perimeter2/4p area): 1–2;
length-to-width ratio: 1–2; average intensity: 250–2000; total intensity:
6 104–56106. The image masks were then used to quantify signals in
other channels. For dose–response and time course experiments, raw
mean values of triplicate samples were normalized to a mean baseline
value from all untreated wells. Bleed-through was compensated as
described previously (Roederer, 2002). Probability density plots were
generated using the R package (1D plots) or FlowJo (2D plots). Gating of
subpopulations was performed either by setting thresholds at local
minima of probability density plots or using threshold free mixture
modeling (see below).
Calcium imaging followed by quantitative microscopy
DRG neurons were plated in 348-well glass-bottomed plates (Greiner;
1000 neurons/well, 80 ml medium) and cultured overnight. Neuron
cultures were loaded with 0.005 mg/ml FURA-2-AM (Invitrogen) in
Neurobasal-A/B27 medium for 40 minutes and washed twice with
medium for 10 minutes. Calcium traces were recorded with the
Cellomics Arrayscan VTI. Calcium influx was induced by
automatically dispensing 5 ml capsaicin (f.c. 250 nM) or KCl (f.c.
30 mM) with the Arrayscans computer-controlled pipettor. Cells were
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fixed with 2% PFA for 20 minutes and immunostained for the respective
markers as described above, outside the microscope. All wells were then
imaged again with the Arrayscan VTI. Using ImageJ, UCHL1 images
were background corrected (rolling ball), converted to binary image
masks (Li thresholding), segmented (water shed), and objects were
identified by their circularity (4p area/perimeter250.5–1) and size (120–
4000 mm2). The single cell masks were then used to determine 340/
380 nm values as well as RIIb and UCHL1 expression levels for each
cell. Then the average calcium traces were calculated for the RIIb(+) and
the RIIb(2) neurons. Average traces of three experiments (means 6
s.e.m.) are shown. Living neurons showed a response .25% over the
baseline to either capsaicin or KCl.
Mixture modeling of stimulus experiments
The gamma probability distribution, given by the density function:
p xð Þ~1 C kð Þhk xk{1e{xh ð1Þ
with shape parameter k, scale parameter h, and ck the gamma function,
has been previously suggested as a model for the intracellular distribution
of proteins (Friedman et al., 2006). Population data from control
experiments were fitted with a gamma distribution by adjusting the
parameters k and h using a maximum-likelihood approach (Choi and
Wette, 1969). For each stimulus experiment a mixture model composed
of two gamma distributions was computed. The first mixture component
was fixed to the distribution obtained from the control experiment, and
the second component was chosen as another gamma distribution with
adjustable parameters. The parameters and the component weights were
optimized with the expectation maximization algorithm implemented in
the software library ‘PyMix’ (Georgi et al., 2010). We used a standard
hypothesis test based on the likelihood ration to test whether the
population model of two gamma distributed subpopulations was
statistically significant compared with a model with a single gamma
distribution. The null hypothesis was that the population is described by a
single gamma distribution, and the alternative hypothesis is that the
population is a mixture of two gamma distributions. We used the test
statistic T522 log L, where L is the likelihood ratio of the null
hypothesis model versus the mixture model (Koch, 2010). For large
sample sizes, the test statistic T is chi-square distributed, and a
significance level of P50.001 is achieved for T$10.83. We judged the
partitioning as statistically significant, if T$10.83 in each of the three
replicates of an experiment.
BRET assay
F11 cells were seeded in 96-well plates (Nunc) coated with collagen
(Roche) at a density of 1.56104 cells/well and cultured in Hams F-12
medium (Sigma-Aldrich) with 15% FCS (PAA) and 1% penicillin and
streptomycin (PAA). The cells were transfected after 24 hours using
Lipofectamine 2000 (Invitrogen). Cells were rinsed with PBS 48 hours
later, treated with the respective reagents for 20 minutes, and the
substrate coelenterazine 400a (Biotrend) was added at a final
concentration of 5 mM in a total volume of 30 ml PBS prior to the
BRET measurement. Light emission was detected with a POLARstar
Omega microplate reader (BMG Labtech). For each well the light output
was taken simultaneously using filters at the wavelengths 410 nm
(680 nm) for the donor and 515 nm (630 nm) for the acceptor.
Emission values obtained with untransfected (n.t.) cells were subtracted,
and BRET signals were calculated as follows: [emission (515 nm)2n.t.
cells (515 nm)]/[emission (410 nm)2n.t. cells (410 nm)]. Control
measurements with cells expressing RLuc alone were included in each
experiment.
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